Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Schaefer

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)|June 1, 2022
Can non-responding mask or mimic drug effects on pregnancy outcome? Evaluation of case characteristics based on the national Embryotox cohortRegina Stegherr, Evelin Beck, Stefanie Hultzsch, et al.
Plos One|July 11, 2013
Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for TeratogenicityMaria Hoeltzenbein, Katja Stieler, Mary Panse, et al.
Statistics in Medicine|December 3, 2019
Estimating cumulative incidence functions in competing risks data with dependent left-truncationRegina Stegherr, Arthur Allignol, Reinhard Meister, et al.
Scientific Reports|December 23, 2024
Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerationsChristof Schaefer, Asher Ornoy, Maurizio Clementi, et al.
British Journal of Clinical Pharmacology|July 24, 2012
Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new featureMarc Oppermann, Stephanie Padberg, Angela Kayser, et al.
Scientific Reports|February 18, 2025
Author Correction: Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Rheumatology (Oxford, England)|December 27, 2013
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort studyCorinna Weber-Schoendorfer, Maria Hoeltzenbein, Evelin Wacker, et al.
Journal of Clinical Gastroenterology|August 4, 2012
Infliximab and adalimumab use during breastfeedingJuliane Fritzsche, Anna Pilch, Dina Mury, et al.
Scientific Reports|January 5, 2024
Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort studyAnne-Katrin Fietz, Marlies Onken, Stephanie Padberg, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Reproductive Toxicology (Elmsford, N.Y.)|June 1, 2022
Can non-responding mask or mimic drug effects on pregnancy outcome? Evaluation of case characteristics based on the national Embryotox cohortRegina Stegherr, Evelin Beck, Stefanie Hultzsch, et al.
Plos One|July 11, 2013
Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for TeratogenicityMaria Hoeltzenbein, Katja Stieler, Mary Panse, et al.
Statistics in Medicine|December 3, 2019
Estimating cumulative incidence functions in competing risks data with dependent left-truncationRegina Stegherr, Arthur Allignol, Reinhard Meister, et al.
Scientific Reports|December 23, 2024
Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerationsChristof Schaefer, Asher Ornoy, Maurizio Clementi, et al.
British Journal of Clinical Pharmacology|July 24, 2012
Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new featureMarc Oppermann, Stephanie Padberg, Angela Kayser, et al.
Scientific Reports|February 18, 2025
Author Correction: Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Rheumatology (Oxford, England)|December 27, 2013
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort studyCorinna Weber-Schoendorfer, Maria Hoeltzenbein, Evelin Wacker, et al.
Journal of Clinical Gastroenterology|August 4, 2012
Infliximab and adalimumab use during breastfeedingJuliane Fritzsche, Anna Pilch, Dina Mury, et al.
Scientific Reports|January 5, 2024
Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort studyAnne-Katrin Fietz, Marlies Onken, Stephanie Padberg, et al.
Pageof 10